Branded

DEERFIELD, Ill. — Walgreens on Monday released the results of a study that showed its pharmacy patients who used a multi-faceted medication adherence program had a 3% higher medication adherence rate and lower healthcare costs than those who use other pharmacies. The results were published in Population Health Management. 

 

LONDON — GBI Research published a report Thursday that noted the U.S. market for opioids will be growing in the coming years. According to the report, the opioid market will hit $17.7 billion by 2021, up from $11 billion in 2014, with a compound annual growth rate of 7%. 

 

The report attributes the growth to a concurrent increase in chronic pain in the United States, stemming from an aging population and more incidences of such chronic diseases as diabetes, obesity, cancer, arthritis and cardiovascular disease. 

DEERFIELD, Ill. - The incidence of flu is beginning to abate across California and Oregon, according to the latest Walgreens Flu Index report. However, flu activity is still relatively high across Wyoming, Montana and Kentucky, according to the report. 

 

The top 10 markets with flu activity for the week of March 27 were: 

 

WASHINGTON — The Federal Trade Commission announced Thursday that it had filed a complaint against Endo Pharmaceuticals and several other drug companies alleging that it violated antitrust laws by paying settlements to drug makers to delay the introduction of generic versions of Opana ER and Lidoderm. 

 

The FTC said this is the first case that’s challenged an agreement to not market an authorized generic of a particular drug, which it calls no-AG commitments. 

 

PARSIPPANY, N.J. — IMS Health on Tuesday published a new report about the potential for biosimilars in the United States and the European Union. The report, “Delivering on the Potential of Biosimilar Medicines:  The Role of Functioning Competitive Markets,” focuses on the savings that biosimilars can deliver for patients and payers, as well as the access to advanced treatments they offer payers.